Quantifying Effector Functions of Anti-HIV IgG1 Antibodies In Vivo.
Quantifying Effector Functions of Anti-HIV IgG1 Antibodies In Vivo.
批准号:
10005113
负责人:
DAVID D HO
金额:
$76.2万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-01 至 2022-08-31
关键词:
AddressAnimalsAntibodiesAntibody ResponseAntibody TherapyAntigen PresentationAntiviral AgentsApplications GrantsAreaBindingBloodCD4 Positive T LymphocytesCellsComplement-Dependent CytotoxicityComplexDataData SetDeath RateDiseaseEnsureEquationFc ReceptorHIVHIV AntibodiesHIV InfectionsHIV vaccineHalf-LifeHumanIgG ReceptorsIgG1Immunoglobulin GImmunologyIn VitroInfectionKnowledgeMacaca mulattaMathematicsMeasuresMediatingMonkeysMusNIH Program AnnouncementsPatientsPersonsPhagocytosisPlasmaPropertySeriesSpecific qualifier valueVaccine DesignVaccinesViralViral AntibodiesViral Load resultViremiaVirionVirusVirus Diseasesantibody-dependent cell cytotoxicityantiretroviral therapycombatcomparativeexpectationexperimental studyhumanized mouseimprovedin vivoinsightmathematical analysismouse modelneutralizing antibodyparticleresponsesimian human immunodeficiency virusvaccine discoveryviral RNAward
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
There is an abundance of evidence demonstrating the importance of Fc-mediated effector function to the overall
activity of an antibody in vivo. However, the relative contribution of virus neutralization versus effector functions
to the antiviral effect of an antibody remains undefined. We have proposed a series of experiments that will
quantify the contributions of Fc-mediated effector functions to the overall activity of an antibody. The quantitative
experiments will be performed in the setting of antibody treatment of SHIV infection in rhesus macaques. These
fundamental questions in immunology have yet to be answered, and the resultant information promises to
provide important insights on how the two major properties (neutralization versus effector functions) of a vaccine-
induced IgG response combine forces to ward off the establishment of HIV infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Multiplex Small Molecule Discovery to Identify Broad-Acting Viral Protease Inhibitors
-
批准号:10513925
-
项目类别:
-
资助金额:$354.56万
-
财政年份:2022
-
负责人:DAVID D HO
-
依托单位:
Quantifying Effector Functions of Anti-HIV IgG1 Antibodies In Vivo.
-
批准号:10078502
-
项目类别:
-
资助金额:$61.45万
-
财政年份:2019
-
负责人:DAVID D HO
-
依托单位:
Quantifying Effector Functions of Anti-HIV IgG1 Antibodies In Vivo.
-
批准号:10239076
-
项目类别:
-
资助金额:$24.77万
-
财政年份:2019
-
负责人:DAVID D HO
-
依托单位:
Quantifying Effector Functions of Anti-HIV IgG1 Antibodies In Vivo.
-
批准号:10866743
-
项目类别:
-
资助金额:$49.98万
-
财政年份:2019
-
负责人:DAVID D HO
-
依托单位:
Bispecific and Trispecific Anti-Env Antibodies for Eliminating HIV Reservoir Cells
-
批准号:10224769
-
项目类别:
-
资助金额:$71.39万
-
财政年份:2017
-
负责人:DAVID D HO
-
依托单位:
Bispecific-Antibody-Drug Conjugates for Selective Targeting and Activation of the HIV Latent Reservoir
-
批准号:10078006
-
项目类别:
-
资助金额:$20.58万
-
财政年份:2017
-
负责人:DAVID D HO
-
依托单位:
Bispecific and Trispecific Anti-Env Antibodies for Eliminating HIV Reservoir Cells
-
批准号:10083601
-
项目类别:
-
资助金额:$36.81万
-
财政年份:2017
-
负责人:DAVID D HO
-
依托单位:
Bispecific-Antibody-Drug Conjugates for Selective Targeting and Activation of the HIV Latent Reservoir
-
批准号:10222490
-
项目类别:
-
资助金额:$49.62万
-
财政年份:2017
-
负责人:DAVID D HO
-
依托单位:
Combination Clostridium Difficile Toxin and Adhesin Vaccine
-
批准号:8686731
-
项目类别:
-
资助金额:$36.25万
-
财政年份:2012
-
负责人:DAVID D HO
-
依托单位:
Combination Clostridium Difficile Toxin and Adhesin Vaccine
-
批准号:8290921
-
项目类别:
-
资助金额:$22.7万
-
财政年份:2012
-
负责人:DAVID D HO
-
依托单位:
Combination Clostridium Difficile Toxin and Adhesin Vaccine
-
批准号:8868011
-
项目类别:
-
资助金额:$35.3万
-
财政年份:2012
-
负责人:DAVID D HO
-
依托单位:
Combination Clostridium Difficile Toxin and Adhesin Vaccine
-
批准号:8501352
-
项目类别:
-
资助金额:$34.95万
-
财政年份:2012
-
负责人:DAVID D HO
-
依托单位:
Monthly Antiretroviral Therapy Using Multispecific HIV Neutralizing Antibodies
-
批准号:8911804
-
项目类别:
-
资助金额:$87.67万
-
财政年份:2011
-
负责人:DAVID D HO
-
依托单位:
Combination Clostridium Difficile Toxin and Adhesin Vaccine
-
批准号:8337121
-
项目类别:
-
资助金额:$74.15万
-
财政年份:2011
-
负责人:DAVID D HO
-
依托单位:
Monthly Antiretroviral Therapy Using Multispecific HIV Neutralizing Antibodies
-
批准号:8716711
-
项目类别:
-
资助金额:$89.0万
-
财政年份:2011
-
负责人:DAVID D HO
-
依托单位:
Monthly Antiretroviral Therapy Using Multispecific HIV Neutralizing Antibodies
-
批准号:8267853
-
项目类别:
-
资助金额:$89.0万
-
财政年份:2011
-
负责人:DAVID D HO
-
依托单位:
Monthly Antiretroviral Therapy Using Multispecific HIV Neutralizing Antibodies
-
批准号:8325003
-
项目类别:
-
资助金额:$89.0万
-
财政年份:2011
-
负责人:DAVID D HO
-
依托单位:
Monthly Antiretroviral Therapy Using Multispecific HIV Neutralizing Antibodies
-
批准号:8522269
-
项目类别:
-
资助金额:$85.44万
-
财政年份:2011
-
负责人:DAVID D HO
-
依托单位:
PHASE I STUDY OF CLADE C DNA VACCINE IN HIV
-
批准号:7207025
-
项目类别:
-
资助金额:$26.08万
-
财政年份:2005
-
负责人:DAVID D HO
-
依托单位:
IN VITRO HIV/SIV ASSAYS USING RHESUS MACAQUE BLOOD
-
批准号:7165023
-
项目类别:
-
资助金额:$6.29万
-
财政年份:2005
-
负责人:DAVID D HO
-
依托单位:
海外基金